HFSA Board Certification Review 2021

[

Heart Failure Fundamentals (Pre-Recorded)
 
Heart Failure Epidemiology and Risk Factors
Sadiya Khan
 
Pathophysiology I: Cellular and Energetic Considerations
Daniel Burkhoff
 
Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations
Daniel Burkhoff
 
Diagnosis and Clinical Assessment
Mark Drazner
 
Cardio-Oncology for the HF boards
Bonnie Ky
 
Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards
Jon Lomasney
 
Statistics for the HF Board
Brian Claggett
 
Cardiac Transplantation
 
Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies
Nancy Sweitzer
 
Immunology: The Basics, PRA, Sensitization, Crossmatch
Sean Pinney
 
Rejection: Cellular and Antibody Mediated
Sean Pinney
 
Managing Immunosuppression and Drugs
Michelle Kittleson
 
Heart Transplant, Clinical Outcomes and Complications
Michelle Kittleson
 
Q&A Panel I
Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
 
Key Issues in HF Management
 
Hemodynamics in HF I
James Fang
 
Hemodynamics in HF II
James Fang
 
Drug Therapy for Chronic HF I: Focus on established therapies (ACE/ARB/Beta-blocker/MRA/Digoxin/Hydralazine+Nitrates)
Clyde Yancy
 
Drug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril/Valsartan, Ivabradine, SGLT2 inhibitors)
Mark Drazner
 
HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)
Sanjiv Shah
 
Pulmonary Hypertension
Jonathan Rich
 
Management of Common Arrhythmias I – Atrial Fib and Flutter
Roderick Tung
 
Management of Common Arrhythmias in HF II
Roderick Tung
 
Device Therapy in Heart Failure I – Sudden Death Prevention
Wendy Tzou
 
Device Therapy in Heart Failure II – CRT
Wendy Tzou
 
Management of the Hospitalized HF Patient
Maria Rosa Costanzo
 
Cardio Renal Failure Interactions in Heart Failure
Jeff Testani
 
Specific Heart Failure Syndromes
 
Specific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)
Akshay Desai
 
Specific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)
Jane Wilcox
 
Specific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)
Sanjiv Shah
 
Q&A Panel II
Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa
Guest: James Fang
 
Shock/MCS
 
Cardiogenic Shock Management
Nancy Sweitzer
 
MCS I: Durable MCS Devices and Outcomes
Joseph Rogers
 
MCS II: Temporary Support Devices and ECMO for the Boards
Jennifer Cowger
 
MCS III: MCS Complications and Patient Management
Jennifer Cowger
 
MCS IV: Interactive Shock and Device Management
Daniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer
 
Special Topics in HF
 
Assessment of Functional Capacity including cardiopulmonary exercise testing
Gregory Lewis
 
Adult Congenital Heart Disease for the HF Specialist
Eric Krieger
 
Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)
Akshay Desai
 
Management of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)
Jane Wilcox
 
Management of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency/Anemia, COPD
Maria Rosa Costanzo
 
Q&A Panel III
Akshay Desai, Nancy Sweitzer, Jonathan Rich

Reviews
There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

]